Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics, organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Albemarle Corporation

Wells Fargo analyst Michael Sison reiterated a Hold rating on Albemarle yesterday and set a price target of $165.00. The company’s shares closed ye...

Albemarle (ALB) Receives a Hold from Wells Fargo

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Autolus Therapeutics (AUTL), Assertio Therapeutics...

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL), Assertio Therapeutics (ASRT) and Alibaba Health Information Technology (OtherALBHF)

In a report released on April 7, from UBS maintained a Sell rating on Alibaba Health Information Technology, with a price target of HK$4.10. The co...

UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)

In a report released yesterday, from CLSA maintained a Buy rating on Alibaba Health Information Technology, with a price target of HK$5.30. In addi...

CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)

Broadpeak SA ( ($FR:ALBPK) ) just unveiled an update. Broadpeak has reported its latest share capital and voting rights structure, disclosing that ...

Broadpeak Updates Market on Share Capital and Voting Rights Structure

Avalon GloboCare ( ($ALBT) ) has shared an update. On April 2, 2026, Avalon Globocare’s board set June 9, 2026, as the date for its 2026 Annual Mee...

Avalon GloboCare Sets New Deadline for Shareholder Nominations

Albemarle ( ($ALB) ) has provided an announcement. On March 19, 2026, Albemarle Corporation and its lenders executed a third amendment to the compa...

Albemarle Amends Credit Facility, Extends Maturity to 2028

Alibaba Health Information Technology ( ($HK:0241) ) has shared an update. Alibaba Health Information Technology has granted 3,881,600 restricted s...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALB	$173.64	0.00%	1.21M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALB	$173.64	0%	1.21M
3
4
5
6

ALB

ALB

Get Albemarle Corporation Data in Excel

Get Albemarle Corporation Data in Excel